Bengaluru, July 1: Indian drugmaker Zydus Cadila (CADI.NS) said on Thursday it has applied to the country’s drug regulator for emergency use approval of its COVID-19 vaccine and that it
Bengaluru, July 1: Indian drugmaker Zydus Cadila (CADI.NS) said on Thursday it has applied to the country’s drug regulator for emergency use approval of its COVID-19 vaccine and that it